STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRWV
  4. [144] CoreWeave, Inc. SEC Filing

CRWV (NASDAQ) Form 144: 12,500 founder shares, $1.02M through MSSB

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CRWV submitted a Form 144 disclosing a proposed sale of 12,500 common founder shares through Morgan Stanley Smith Barney LLC, with an aggregate dollar amount shown as $1,021,812.50 and an entry date of 07/06/2026. The filing also lists multiple recent 10b5-1 sales by related holders; examples include Brannin McBee selling 56,707 shares on 06/30/2026 and Meghan Bennett selling 144,000 shares on 06/29/2026.

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists a 12,500-share founder resale and shows multiple recent 10b5-1 sales.

The notice identifies 12,500 common founder shares proposed for sale through Morgan Stanley Smith Barney LLC with an associated dollar figure of $1,021,812.50 and a listed date of 07/06/2026. This is a regulatory disclosure of a proposed resale under Section 144.

Reported prior transactions are labeled as 10b5-1 sales, which the excerpt lists by holder, date, share count, and dollar amounts. Cash‑flow treatment and whether the company receives proceeds are not described in the provided excerpt; subsequent filings or broker reports would clarify execution details.

Shares offered 12,500 shares Securities To Be Sold / Founders Shares
Aggregate dollar figure $1,021,812.50 Line with 12,500 shares and Morgan Stanley Smith Barney LLC
Entry date 07/06/2026 Date shown on the 12,500-share line
Example sale — Brannin McBee 56,707 shares Sale on 06/30/2026 for $5,426,292.83
Example sale — Meghan Bennett 144,000 shares Sale on 06/29/2026 for $13,582,699.20
Example sale — April 27 bundle 200,000 shares Sale on 04/27/2026 for $21,806,780.00 (Brannin McBee entry)
Form 144 regulatory
"disclosing a proposed sale of 12,500 common founder shares"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
10b5-1 sales regulatory
"listed as 10b5-1 Sales for BRANNIN MCBEE on 06/30/2026"
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.
Founders Shares market
"Securities To Be Sold | Common | Founders Shares | Issuer"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does CRWV's Form 144 disclose?
It discloses a proposed resale of 12,500 common founder shares with an aggregate amount shown as $1,021,812.50, dated 07/06/2026. The filing names Morgan Stanley Smith Barney LLC as the broker for the sale.

Does the filing show recent insider sales for CRWV?
Yes. The excerpt lists multiple 10b5-1 sales by related holders, including 56,707 shares sold by Brannin McBee on 06/30/2026 and 144,000 shares sold by Meghan Bennett on 06/29/2026.

Who is listed as the broker in the Form 144?
The broker named in the filing is Morgan Stanley Smith Barney LLC, with an address noted as 1 New York Plaza, 8th Floor, New York, NY 10004. The broker is associated with the 12,500-share line in the excerpt.

Are proceeds to the issuer stated in this excerpt?
The excerpt shows an aggregate dollar figure of $1,021,812.50 tied to the 12,500-share line, but it does not state whether the issuer will receive proceeds. The cash‑flow treatment is not specified in the provided text.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR